Key Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$184K Hold
1,168
– – 0.03% 312
2026
Q2
$185K Hold
1,168
– – 0.03% 316
2026
Q1
$149K Hold
1,168
– – 0.03% 339
2025
Q4
$142K Buy
1,168
+2
+0.2% +$229 0.03% 340
2025
Q3
$118K Hold
1,166
– – 0.02% 364
2025
Q2
$96.7K Hold
1,166
– – 0.02% 389
2025
Q1
$94.5K Hold
1,166
– – 0.02% 370
2024
Q4
$105K Buy
1,166
+400
+52% +$38.8K 0.02% 340
2024
Q3
$75.6K Buy
766
+151
+25% +$14.8K 0.02% 406
2024
Q2
$57.1K Hold
615
– – 0.01% 440
2024
Q1
$58.4K Hold
615
– – 0.01% 412
2023
Q4
$54.9K Hold
615
– – 0.02% 410
2023
Q3
$44.9K Hold
615
– – 0.02% 425
2023
Q2
$51.2K Hold
615
– – 0.02% 405
2023
Q1
$46.9K Sell
615
-150
-20% -$12.4K 0.02% 402
2022
Q4
$60.7K Hold
765
– – 0.03% 331
2022
Q3
$61K Hold
765
– – 0.03% 333
2022
Q2
$59K Hold
765
– – 0.03% 330
2022
Q1
$69K Buy
765
+500
+189% +$46.2K 0.03% 320
2021
Q4
$30K Hold
265
– – 0.02% 419
2021
Q3
$33K Hold
265
– – 0.02% 394
2021
Q2
$33K Hold
265
– – 0.02% 404
2021
Q1
$36K Hold
265
– – 0.02% 328
2020
Q4
$37K Buy
+265
New +$33.9K 0.03% 294
2020
Q2
– Sell
-265
Closed -$21K – 660
2020
Q1
$21K Buy
+265
New +$23.5K 0.02% 320

Other funds holding XBI

Key Financial's XBI Position: Q3 2026 in Review

Key Financial held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 1,168 shares worth $184K. The position accounts for 0.03% of the portfolio, ranked #312.

Key Financial first reported a position in XBI in Q1 2020 and has held it in 25 quarters since. The position peaked at $185K in Q2 2026. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Key Financial held 1,168 shares of State Street SPDR S&P Biotech ETF worth $184K as of Q3 2026.
  • Key Financial left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Key Financial's portfolio in Q3 2026, its #312 holding.
  • Key Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 25 quarters since.
  • Key Financial's State Street SPDR S&P Biotech ETF position peaked at $185K in Q2 2026.
  • 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.